Continuing bisphosphonate treatment for osteoporosis--for whom and for how long?

N Engl J Med. 2012 May 31;366(22):2051-3. doi: 10.1056/NEJMp1202623. Epub 2012 May 9.
No abstract available

MeSH terms

  • Bone Density / drug effects
  • Bone Density Conservation Agents / administration & dosage*
  • Bone Density Conservation Agents / pharmacology
  • Diphosphonates / administration & dosage*
  • Diphosphonates / pharmacology
  • Drug Administration Schedule
  • Fractures, Bone / epidemiology
  • Fractures, Bone / prevention & control*
  • Humans
  • Osteoporosis / drug therapy*
  • Risk
  • Spinal Fractures / epidemiology
  • Spinal Fractures / prevention & control

Substances

  • Bone Density Conservation Agents
  • Diphosphonates